ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,254.96
0.65%
Dow Jones
42,518.28
0.00%
Gold vs US Dollar
2,684.28
0.59%
Brent Oil
79.905
0.26%
Bitcoin
98,409.80
1.97%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Paratek Pharmaceuticals Inc (PRTK)

  7. Paratek Pharmaceuticals Inc (PRTK) News

Paratek Pharmaceuticals (PRTK)

Paratek Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PRTK
DateTimeSourceHeadlineSymbolCompany
05/10/202312:00GlobeNewswire Inc.Paratek Pharmaceuticals to Present NUZYRA Data at IDWeek 2023NASDAQ:PRTKParatek Pharmaceuticals Inc
02/10/202311:33Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:PRTKParatek Pharmaceuticals Inc
26/09/202304:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202317:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202317:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202317:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202317:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202317:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202317:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202317:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202317:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202317:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202317:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202317:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202317:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202314:59Edgar (US Regulatory)Form SC 13E3/A - Going private transaction by certain issuers: [Amend]NASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202314:42Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202314:39Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202314:37Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202314:32Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202314:30Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202314:28Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202314:26Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202314:24Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202314:21Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202314:18Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202314:16Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202314:14Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202314:12Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:PRTKParatek Pharmaceuticals Inc
21/09/202314:10Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:PRTKParatek Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PRTK

Your Recent History

BIT
F35321
Vontobel Financial Produ...
BIT
F25173
Vontobel Financial Produ...
BIT
UC69DP
Unicredit Bank
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads